MedPath

Comparing the efficacy of Ticagrelor and Clopidogrel in patients with Acute ischemic attack or Transient ischemic attack(TIA)

Phase 2
Recruiting
Conditions
Acute Ischemic Stroke.
Cerebral infarction
Registration Number
IRCT20130311012781N6
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
424
Inclusion Criteria

Diagnosing Ischemic Stroke or TIA based on history and neurological examination and Imaging findings by a Specialist

Exclusion Criteria

More than 24 hours have passed since the onset of symptoms
Thrombolytic therapy or Thrombectomy
Intracranial hemorrhage
Vascular malformations
The presence of contraindications to Aspirin, Clopidogrel or Ticagrelor
Severe or moderate Ischemic Stroke (NIHSS>>12)
Lack of patient consent to enter the study
The presence of acute coronary syndrome at the beginning of hospitalization
cardioembolic Stroke or TIA

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrence of stroke. Timepoint: 21 days, 3 months, 6 months from the beginning of the study. Method of measurement: Clinical history and in case of recurrence of stroke symptoms, imaging findings.
Secondary Outcome Measures
NameTimeMethod
Intracranial hemorrhage, Dyspnea, Mortality. Timepoint: 21 days, 3 months, 6 months from the beginning of the study. Method of measurement: Clinical history and Imaging findings in case of Symptoms related to Intracranial hemorrhage or Dyspnea.
© Copyright 2025. All Rights Reserved by MedPath